protein farnesyltransferase inhibitor ameliorates disease mouse model progeria 
progerias rare genetic diseases characterized premature aging several progeroid disorders caused mutations lead accumulation lipid-modified farnesylated form prelamin protein contributes structural scaffolding cell nucleus progeria accumulation farnesyl-prelamin disrupts scaffolding leading misshapen nuclei previous studies shown farnesyltransferase inhibitors ftis reverse cellular abnormality tested efficacy fti abt- zmpste24-deficient mice mouse model progeria fti-treated mice exhibited improved body weight grip strength bone integrity percent survival weeks age results suggest ftis may beneficial effects humans progeria 
